IL-23/IL-17 Biology and Therapeutic Considerations
Author:
Publisher
Informa UK Limited
Subject
Toxicology,Immunology
Link
http://www.tandfonline.com/doi/pdf/10.1080/15476910801897953
Reference17 articles.
1. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2. Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor
3. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
4. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
5. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease;Rheumatology International;2024-03-20
2. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01
3. Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study;Dermatology and Therapy;2022-09-28
4. Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-07
5. Th17 cells in the liver: balancing autoimmunity and pathogen defense;Seminars in Immunopathology;2022-02-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3